Related Topics News -

     
 Detail   |   Print 
     
寶濟藥業注射用KJ103上市許可申請獲國家藥監局受理
2026-06-04T  
寶濟藥業確認不悉股價波動原因 主席擬增持
2026-05-03T  
寶濟藥業大成交急瀉64% 3月上旬獲納入港股通
2026-04-30T  
寶濟藥業注射用人玻璃酸酶獲批上市
2026-04-08T  
《業績》寶濟藥業全年虧損擴大至3.95億人幣
2026-03-26T  
寶濟藥業KJ103用於腎移植脫敏治療III期臨床試驗完成隨訪 將提交新藥上市申請
2026-03-25T  
寶濟藥業KJ101新增適應症臨床試驗獲批
2026-03-12T  
寶濟藥業獲納入港股通證券名單
2026-03-09T  
寶濟藥業擬實施H股全流通計劃
2025-12-30T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.